The Toolbox is under development. HEDIMED aims to create two different kind of platforms: The Research Platform for internal use of HEDIMED and The Public Platform.
HEDIMED Public platform
The decision makers can use the HEDIMED Public Platform to get information and to study selected data, project findings and simulations related to the exposome’s effects on the development of type 1 diabetes, celiac disease, allergies and asthma. The citizens and other stakeholders can similarly access the Public Platform to study and visualize selected data and analysis results.
The toolbox will offer resources for stakeholders, policy makers and general public to get information, visualize and model medical and socioeconomical outcomes and effects of the exposome on immune-mediated diseases.